Pages that link to "Q58197395"
Jump to navigation
Jump to search
The following pages link to Signalling networks associated with urokinase‐type plasminogen activator (uPA) and its inhibitor PAI‐1 in breast cancer tissues: new insights from protein microarray analysis (Q58197395):
Displaying 27 items.
- Platelets, coagulation and fibrinolysis in breast cancer progression (Q26823716) (← links)
- Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas (Q28728855) (← links)
- Common protein biomarkers assessed by reverse phase protein arrays show considerable intratumoral heterogeneity in breast cancer tissues (Q34336095) (← links)
- Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues (Q34422523) (← links)
- Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping (Q34436356) (← links)
- mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch (Q34463393) (← links)
- Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer (Q34552074) (← links)
- Variation in cell signaling protein expression may introduce sampling bias in primary epithelial ovarian cancer (Q35035679) (← links)
- Recent progress in protein profiling of clinical tissues for next-generation molecular diagnostics (Q35714211) (← links)
- uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R. (Q36097941) (← links)
- Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA) (Q36134032) (← links)
- Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients. (Q36557197) (← links)
- An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays (Q36578468) (← links)
- Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer (Q37711623) (← links)
- Inflammation and cancer: till death tears them apart (Q38485607) (← links)
- Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression (Q38734026) (← links)
- Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells (Q38875428) (← links)
- Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up (Q41725997) (← links)
- uPA and PAI-1-Related Signaling Pathways Differ between Primary Breast Cancers and Lymph Node Metastases (Q41878395) (← links)
- Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance. (Q44238245) (← links)
- Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients. (Q47146356) (← links)
- Transforming growth factor-beta signaling leads to uPA/PAI-1 activation and metastasis: a study on human breast cancer tissues. (Q47604922) (← links)
- Altered expression of telomere-associated genes in leukocytes among BRCA1 and BRCA2 carriers (Q47782009) (← links)
- Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors (Q50101328) (← links)
- Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR. (Q54605761) (← links)
- Silencing of ELK3 Induces S-M Phase Arrest and Apoptosis and Upregulates SERPINE1 Expression Reducing Migration in Prostate Cancer Cells (Q89911589) (← links)
- SerpinB2 inhibits migration and promotes a resolution phase signature in large peritoneal macrophages (Q92913990) (← links)